Events

Join Our
Education Events

Stay up to date on the latest news, breakthroughs, and technologies in the world of Histotripsy. Find out more at one of our upcoming events.
The HistoSonics device in operation

Introduction to Histotripsy | Minneapolis, MN

On-Site Events Held Monthly

Agenda

  • Histotripsy Mechanism of Action
  • Hands-On Demonstration
  • Clinical Evidence Plan
  • Coding and Reimbursement
Learn More

Spectrum

1/15/26 - 1/17/26 | Miami, FL

SPECTRUM offers a comprehensive review of multiple oncological diseases, combined with the latest developments in medical, interventional and surgical options across multiple disciplines.

Visit the HistoSonics Booth #107/108 for a live demonstration and discussion

Learn More

Society of Interventional Oncology (SIO)

2/4/26 - 2/8/26 | Savannah, GA

This premier event provides comprehensive learning sessions, opportunities for face-to-face networking, and skill-building activities for leading interventional oncology (IO) practitioners from across the globe.

Visit the HistoSonics Booth #500 for a live demonstration and discussion

Learn More

Society of Surgical Oncology (SSO)

3/5/26 -3/7/26 | Phoenix, AZ

Thisyear’s program offers new educational sessions, disease-site specific content, programming specifically for advanced practice providers, residents and fellows, friendly competition, and new networking opportunities.

Visit the HistoSonics Booth for a live demonstration and discussion

Learn More

AHPBA

3/19/26 - 3/22/26 | Miami Beach, FL

The Americas Hepato-Pancreato-Biliary Association (AHPBA), an incorporated, nonprofit organization, was created with a vision of devoting itself to relieving the human suffering caused by HPB disorders throughout the world, by improving education, training, innovation, research and patient care.

Visit the HistoSonics Booth for a live demonstration and discussion

Learn More

Our team is bringing the power of histotripsy to patients and physicians around the world.

Meet The Team

Last updated on October 30, 2025

Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.

The is intended for the non-invasive mechanical destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors via histotripsy. The FDA has not evaluated the for the treatment of any disease including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumor progression, 5-year survival or overall survival). The System should only be used by persons who have completed training performed by HistoSonics Inc., and its use guided by the clinical judgment of an appropriately trained physician. Refer to the device Instructions for Use for a complete list of warnings, precautions and a summary of clinical trial results, including reported adverse events.

Footer last updated on June 30, 2025
X New Twitter Logo
© 2019-2025 HistoSonics®. All rights reserved.
HistoSonics
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.